Reverse CellularAging with AI.
Patho.ai is advancing a gated cellular rejuvenation program around AP2A1, the AP-2 complex alpha subunit implicated in aging-state biology.
Platform Capabilities
The entire drug discovery lifecycle, accelerated by generative AI.
AP2A1 Target Intelligence
Public materials disclose the target only. Candidate designs, structural hypotheses, and validation data remain restricted to approved investors and customers.
Gated Biology Graph
Powered by Neo4j. Map aging-state literature, pathway evidence, and program milestones without exposing confidential molecule strategy.
Hardware-Accelerated Screening
Evaluate protected design spaces using accelerated compute while keeping sequence, synthesis, and assay details out of public view.
AP2A1 Target Preview
Public visitors can see the program focus and platform direction. The interactive molecular workflow, candidate rationale, and validation package are reserved for verified investor and customer access.
- Visual validation of AI predictions
- Hardware-accelerated Three.js rendering
- Interactive atom-level inspection
Interactive Canvas Initializing
Build the Future of MedTech
Join the revolution today. With a $0 cost-to-run architecture, you can scale infinitely.
Launch Prototype Now